Lv42
550 积分 2024-05-10 加入
Muscle matters: the effects of medically induced weight loss on skeletal muscle
5小时前
已完结
Decreasing the Effects of Aldosterone in Resistant Hypertension — A Success Story
1天前
已完结
Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
1天前
已完结
Hypertension and Lorundrostat: Key Discoveries From the TARGET-HTN Trial
3天前
已完结
Emerging Therapies for Treatment-Resistant Hypertension: A Review of Lorundrostat and Related Selective Aldosterone Synthase Inhibitors
3天前
已完结
Asundexian versus Apixaban in Patients with Atrial Fibrillation
1个月前
已完结
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
1个月前
已完结
Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis
1个月前
已完结
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
1个月前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
3个月前
已完结
皖公网安备34019202002308
